Zdrowie i gospodarka · 18/11/2016

FDA Drafts Guidance for BCG-Resistant Bladder Cancer Treatment

The FDA is releasing a draft guidance to help pharmaceutical companies develop new treatments for a rare and aggressive form of bladder cancer, which has limited treatment options and high mortality rates.